Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of dental caries-associated oxidative stress by different restorative materials: A salivary malondialdehyde-based <i>in vivo study</i>.

Journal of conservative dentistry and endodontics·2026
Same author

Correction: Correlation of Sarcopenia With Modified Frailty Index as a Predictor of Outcome in Critically Ill Elderly Patients: A Cross-Sectional Study.

Cureus·2025
Same author

Comparative Evaluation of Masticatory Bite Force of Implant-Supported Overdenture With Different Attachments: An In Vivo Study.

Cureus·2025
Same author

Lightweight self-attention and deep gated neural network (LSA-DGNet) for multiple neurological disease detection.

Computational biology and chemistry·2025
Same author

Psychological assessment in edentulous patients before and after complete denture.

Bioinformation·2025
Same author

Satisfaction among edentulous patients before and after conventional complete denture.

Bioinformation·2025

Related Experiment Video

Updated: May 4, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

13.5K

Enhanced EEG-based Alzheimer's disease detection using synchrosqueezing transform and deep transfer learning.

Shraddha Jain1, Rajeev Srivastava1

  • 1Department of Computer Science and Engineering, Indian Institute of Technology (IIT), BHU, Varanasi Uttar Pradesh, India, 221011.

Neuroscience
|April 26, 2025
PubMed
Summary

This study introduces an advanced Alzheimer's detection method using electroencephalogram (EEG) signals. The model achieves high accuracy in identifying Alzheimer's disease by analyzing brainwave patterns.

Keywords:
Alzheimer’s diseaseCNNDeep learningEEG signalsInceptionV3Synchrosqueezing transform

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

39.7K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931

Related Experiment Videos

Last Updated: May 4, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

13.5K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

39.7K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease is a progressive neurodegenerative disorder impacting memory, cognition, and behavior.
  • Early and accurate detection is crucial for managing the disease's impact on daily functioning.

Purpose of the Study:

  • To develop and evaluate an electroencephalogram (EEG)-based classification model for Alzheimer's disease detection.
  • To compare the performance of different pre-trained convolutional neural networks (CNNs) for classifying EEG signals.

Main Methods:

  • EEG signals were transformed into image patterns using the synchrosqueezing technique.
  • Fine-tuned pre-trained CNNs (SqueezeNet, ResNet, InceptionV3, MobileNet) were used to classify these EEG images.
  • Classification performance was evaluated using signals from 19 scalp electrodes, focusing on P3 and T5 channels.

Main Results:

  • The InceptionV3 model demonstrated the highest classification accuracy, achieving 98.50% for the P3 channel and 97.57% for the T5 channel.
  • The P3 and T5 channels were identified as the most effective for Alzheimer's detection.
  • The study confirmed that electrical activity in the parietal and temporal lobes reflects typical disease dynamics.

Conclusions:

  • The proposed EEG-based classification model using synchrosqueezing and CNNs shows significant potential for accurate Alzheimer's disease detection.
  • The findings highlight the efficacy of specific EEG channels (P3, T5) and the InceptionV3 architecture for this diagnostic task.
  • This approach offers a non-invasive method to identify Alzheimer's, reflecting underlying cortical electrical activity patterns.